Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dhampur Bio Organics reported strong FY2026 results with standalone revenue growing 14.4% to Rs 3,106 Crore from Rs 2,714 Crore in FY2025. Profit after tax more than doubled to Rs 24.97 Crore from Rs 12.09 Crore, representing 107% PAT growth. The board declared a dividend of Rs 1.50 per share (15%) subject to shareholder approval. Key corporate actions include acquisition of Sonitron Chemicals Private Limited, re-designation of Gautam Goel as Chairman and CEO, and amendments to Articles of Association. The Income Tax Department conducted a search under Section 132 in October-November 2025 at company premises, but no adjustments were made to the financial results. Additionally, the company sold its Meerganj sugar unit for Rs 305 Crore via slump sale. The auditor issued an unmodified (clean) opinion.
The company demonstrated strong profitability growth with PAT more than doubling year-on-year. The dividend declaration and upcoming sale of the Meerganj unit (Rs 305 Crore) are positive signals for shareholders. The Income Tax search may raise investor concerns but management believes no adjustments are required.